Vaccination against COVID-19 protects people with B-cell lymphoma and multiple myeloma
People with hematological malignancies are at increased risk of severe coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); However, studies examining the immune response to the COVID-19 vaccine are rare. A recently nature cancer A study has documented that people with B-cell lymphoma (LY) and multiple myeloma (MM) develop potent …
Vaccination against COVID-19 protects people with B-cell lymphoma and multiple myeloma Read More »